OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Development of Alzheimer’s Disease Biomarkers: From CSF- to Blood-Based Biomarkers
Sakulrat Mankhong, Sujin Kim, Seongju Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 850-850
Open Access | Times Cited: 40
Sakulrat Mankhong, Sujin Kim, Seongju Lee, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 850-850
Open Access | Times Cited: 40
Showing 1-25 of 40 citing articles:
GFAP as a Potential Biomarker for Alzheimer’s Disease: A Systematic Review and Meta-Analysis
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Cells (2023) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 132
Ka Young Kim, Ki Young Shin, Keun‐A Chang
Cells (2023) Vol. 12, Iss. 9, pp. 1309-1309
Open Access | Times Cited: 132
Optical nanomaterial-based detection of biomarkers in liquid biopsy
Young Jun Kim, Won‐Yeop Rho, Seung Min Park, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Young Jun Kim, Won‐Yeop Rho, Seung Min Park, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 16
Electrochemical Technology for the Detection of Tau Proteins as a Biomarker of Alzheimer’s Disease in Blood
Jianman Wang, Xing Lü, Yao He
Biosensors (2025) Vol. 15, Iss. 2, pp. 85-85
Open Access | Times Cited: 1
Jianman Wang, Xing Lü, Yao He
Biosensors (2025) Vol. 15, Iss. 2, pp. 85-85
Open Access | Times Cited: 1
Harnessing the potentials of machine learning models in Alzheimer's disease prediction and detection
Bhanu Priya, Pranav Gupta, Shantanu Singh
Elsevier eBooks (2025), pp. 259-267
Closed Access | Times Cited: 1
Bhanu Priya, Pranav Gupta, Shantanu Singh
Elsevier eBooks (2025), pp. 259-267
Closed Access | Times Cited: 1
Electrochemical Immunosensors Developed for Amyloid-Beta and Tau Proteins, Leading Biomarkers of Alzheimer’s Disease
Abhinav Sharma, Lúcio Angnes, N. Sattarahmady, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 742-742
Open Access | Times Cited: 21
Abhinav Sharma, Lúcio Angnes, N. Sattarahmady, et al.
Biosensors (2023) Vol. 13, Iss. 7, pp. 742-742
Open Access | Times Cited: 21
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Multi-Omic Blood Biomarkers as Dynamic Risk Predictors in Late-Onset Alzheimer’s Disease
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Oneil G. Bhalala, Rosie Watson, Nawaf Yassi
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1231-1231
Open Access | Times Cited: 6
Evaluation of serum neurofilament light chain and glial fibrillary acidic protein in the diagnosis of Alzheimer’s disease
Tangni Fang, Yaqian Dai, Xueyi Hu, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Tangni Fang, Yaqian Dai, Xueyi Hu, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 6
Biomarkers in Alzheimer’s disease
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Kayalvizhi Rajendran, Uma Maheswari Krishnan
Clinica Chimica Acta (2024) Vol. 562, pp. 119857-119857
Closed Access | Times Cited: 5
Data Mining of Microarray Datasets in Translational Neuroscience
Lance M. O’Connor, Blake A. O’Connor, Jialiu Zeng, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1318-1318
Open Access | Times Cited: 13
Lance M. O’Connor, Blake A. O’Connor, Jialiu Zeng, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1318-1318
Open Access | Times Cited: 13
Implementation of an ultra-sensitive microwell-based electrochemical sensor for the detection of Alzheimer’s disease
Soumi Roy, Sarang Kang, Kyu Yeong Choi, et al.
Biosensors and Bioelectronics (2023) Vol. 247, pp. 115898-115898
Closed Access | Times Cited: 11
Soumi Roy, Sarang Kang, Kyu Yeong Choi, et al.
Biosensors and Bioelectronics (2023) Vol. 247, pp. 115898-115898
Closed Access | Times Cited: 11
Scope of Nanomaterials in Treating Neurological Disorders
Aaryan Gupta, Arpita Roy, Kirtanjot Kaur, et al.
OBM Neurobiology (2024) Vol. 08, Iss. 01, pp. 1-22
Open Access | Times Cited: 4
Aaryan Gupta, Arpita Roy, Kirtanjot Kaur, et al.
OBM Neurobiology (2024) Vol. 08, Iss. 01, pp. 1-22
Open Access | Times Cited: 4
Exploratory Tau PET/CT with [11C]PBB3 in Patients with Suspected Alzheimer’s Disease and Frontotemporal Lobar Degeneration: A Pilot Study on Correlation with PET Imaging and Cerebrospinal Fluid Biomarkers
Joachim Strobel, Elham Yousefzadeh-Nowshahr, Katharina Deininger, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 4
Joachim Strobel, Elham Yousefzadeh-Nowshahr, Katharina Deininger, et al.
Biomedicines (2024) Vol. 12, Iss. 7, pp. 1460-1460
Open Access | Times Cited: 4
Distinctive associations between plasma p-tau181 levels and hippocampal subfield volume across the Alzheimer's disease continuum
A Rich, Hwamee Oh
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A Rich, Hwamee Oh
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
SERS-Based Optical Nanobiosensors for the Detection of Alzheimer’s Disease
Feng Gao, Fang Li, Jianhao Wang, et al.
Biosensors (2023) Vol. 13, Iss. 9, pp. 880-880
Open Access | Times Cited: 10
Feng Gao, Fang Li, Jianhao Wang, et al.
Biosensors (2023) Vol. 13, Iss. 9, pp. 880-880
Open Access | Times Cited: 10
Blood biomarker profiles in young-onset neurocognitive disorders: A cohort study
Oneil G. Bhalala, Jessica Beamish, Dhamidhu Eratne, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Open Access
Oneil G. Bhalala, Jessica Beamish, Dhamidhu Eratne, et al.
Australian & New Zealand Journal of Psychiatry (2025)
Open Access
Developing Non-Invasive Molecular Markers for Early Risk Assessment of Alzheimer's Disease
Tapas Kumar Sur, Tanmoy Mondal, Zarish Noreen, et al.
Biomarkers in Neuropsychiatry (2025), pp. 100120-100120
Open Access
Tapas Kumar Sur, Tanmoy Mondal, Zarish Noreen, et al.
Biomarkers in Neuropsychiatry (2025), pp. 100120-100120
Open Access
Integrating NLP and LLMs to discover biomarkers and mechanisms in Alzheimer's disease
Jin‐Won Song, Junjie Huang, Richen Liu
SLAS TECHNOLOGY (2025), pp. 100257-100257
Open Access
Jin‐Won Song, Junjie Huang, Richen Liu
SLAS TECHNOLOGY (2025), pp. 100257-100257
Open Access
Blood-Based β-Amyloid and Phosphorylated Tau (p-Tau) Biomarkers in Alzheimer’s Disease: A Systematic Review of Their Diagnostic Potential
Meghana Dasari, Joel Abraham Kurian, Sumanth Gundraju, et al.
Cureus (2025)
Open Access
Meghana Dasari, Joel Abraham Kurian, Sumanth Gundraju, et al.
Cureus (2025)
Open Access
Success of anti-amyloid therapy answers few but raises many questions
Atanu Biswas
Annals of Medical Science and Research (2025) Vol. 4, Iss. 1, pp. 1-3
Closed Access
Atanu Biswas
Annals of Medical Science and Research (2025) Vol. 4, Iss. 1, pp. 1-3
Closed Access
Increase in Mitochondrial D-Loop Region Methylation Levels in Mild Cognitive Impairment Individuals
Andrea Stoccoro, Filippo Baldacci, Roberto Ceravolo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5393-5393
Open Access | Times Cited: 16
Andrea Stoccoro, Filippo Baldacci, Roberto Ceravolo, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5393-5393
Open Access | Times Cited: 16
Direct Oral Anticoagulants (DOACs) for Therapeutic Targeting of Thrombin, a Key Mediator of Cerebrovascular and Neuronal Dysfunction in Alzheimer’s Disease
Klaus Großmann
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1890-1890
Open Access | Times Cited: 16
Klaus Großmann
Biomedicines (2022) Vol. 10, Iss. 8, pp. 1890-1890
Open Access | Times Cited: 16
The human neurosecretome: extracellular vesicles and particles (EVPs) of the brain for intercellular communication, therapy, and liquid-biopsy applications
Taliah Soleymani, Tzu-Yi Chen, Edgar Gonzalez‐Kozlova, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
Taliah Soleymani, Tzu-Yi Chen, Edgar Gonzalez‐Kozlova, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8
A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer’s Disease
Yunxing Ma, Julia Brettschneider, Joanna F. Collingwood
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1713-1713
Open Access | Times Cited: 12
Yunxing Ma, Julia Brettschneider, Joanna F. Collingwood
Biomedicines (2022) Vol. 10, Iss. 7, pp. 1713-1713
Open Access | Times Cited: 12
A streamlined, resource-efficient immunoprecipitation-mass spectrometry method for quantifying plasma amyloid-β biomarkers in Alzheimer's disease
Thomas K. Karikari, Yijun Chen, Xuemei Zeng, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
Thomas K. Karikari, Yijun Chen, Xuemei Zeng, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2
